
Stablecoin Development Corp. (AMEX: SDEV) Stock Competitors & Peer Comparison
See SDEV's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SDEV and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SDEV | $1.14 | +1.79% | 57M | -0.20 | -$5.73 | +341.88% |
| RPRX | $61.31 | +1.21% | 27.2B | 11.68 | $5.25 | +1.50% |
| CORT | $122.25 | +2.71% | 13.1B | 345.86 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $68.62 | -3.42% | 6.1B | 490.14 | $0.14 | N/A |
| KNSA | $79.03 | +0.71% | 6B | 87.81 | $0.90 | N/A |
| PBH | $51.31 | +1.56% | 2.4B | 11.61 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| LTGO | $22.37 | +4.53% | 1.3B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
SDEV vs RPRX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, RPRX has a market cap of 27.2B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while RPRX trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas RPRX's P/E ratio is 11.68. In terms of profitability, SDEV's ROE is +7.90%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, SDEV is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
SDEV vs CORT Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CORT has a market cap of 13.1B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CORT trades at $122.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CORT's P/E ratio is 345.86. In terms of profitability, SDEV's ROE is +7.90%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SDEV is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
SDEV vs WBA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas WBA's P/E ratio is -1.64. In terms of profitability, SDEV's ROE is +7.90%, compared to WBA's ROE of -0.42%. Regarding short-term risk, SDEV is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
SDEV vs LQDA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, LQDA has a market cap of 6.1B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while LQDA trades at $68.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas LQDA's P/E ratio is 490.14. In terms of profitability, SDEV's ROE is +7.90%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, SDEV is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
SDEV vs KNSA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while KNSA trades at $79.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas KNSA's P/E ratio is 87.81. In terms of profitability, SDEV's ROE is +7.90%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, SDEV is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check KNSA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
SDEV vs PBH Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while PBH trades at $51.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas PBH's P/E ratio is 11.61. In terms of profitability, SDEV's ROE is +7.90%, compared to PBH's ROE of +0.09%. Regarding short-term risk, SDEV is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
SDEV vs HROWL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas HROWL's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, SDEV is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check HROWL's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
SDEV vs LTGO Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, LTGO has a market cap of 1.3B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while LTGO trades at $22.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas LTGO's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to LTGO's ROE of N/A. Regarding short-term risk, SDEV is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check LTGO's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
SDEV vs HROWM Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas HROWM's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, SDEV is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check HROWM's competition here
Cybin Inc. Common Stock (NASDAQ: HELP)
SDEV vs HELP Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, HELP has a market cap of 780.4M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while HELP trades at $12.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas HELP's P/E ratio is -3.02. In terms of profitability, SDEV's ROE is +7.90%, compared to HELP's ROE of -0.71%. Regarding short-term risk, SDEV is more volatile compared to HELP. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
SDEV vs SVA Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas SVA's P/E ratio is -5.68. In terms of profitability, SDEV's ROE is +7.90%, compared to SVA's ROE of -0.01%. Regarding short-term risk, SDEV is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
SDEV vs CUVL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CUVL has a market cap of 390.3M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CUVL trades at $7.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CUVL's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to CUVL's ROE of N/A. Regarding short-term risk, SDEV is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
SDEV vs HITI Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, HITI has a market cap of 215.3M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while HITI trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas HITI's P/E ratio is 61.25. In terms of profitability, SDEV's ROE is +7.90%, compared to HITI's ROE of -0.43%. Regarding short-term risk, SDEV is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
SDEV vs CELG-RI Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CELG-RI has a market cap of 208.4M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, SDEV is less volatile compared to CELG-RI. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check CELG-RI's competition here
Atlantic International Corp. (NASDAQ: ATLN)
SDEV vs ATLN Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas ATLN's P/E ratio is -0.68. In terms of profitability, SDEV's ROE is +7.90%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, SDEV is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
SDEV vs CTOR Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CTOR has a market cap of 70.6M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CTOR trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CTOR's P/E ratio is -1.62. In terms of profitability, SDEV's ROE is +7.90%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, SDEV is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CTOR's competition here
Rite Aid Corporation (NYSE: RAD)
SDEV vs RAD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas RAD's P/E ratio is -0.05. In terms of profitability, SDEV's ROE is +7.90%, compared to RAD's ROE of +2.76%. Regarding short-term risk, SDEV is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
SDEV vs GLTO Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas GLTO's P/E ratio is -1.78. In terms of profitability, SDEV's ROE is +7.90%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, SDEV is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
SDEV vs NSRX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, NSRX has a market cap of 34.5M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while NSRX trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas NSRX's P/E ratio is -5.56. In terms of profitability, SDEV's ROE is +7.90%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, SDEV is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
SDEV vs SCYX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, SCYX has a market cap of 32.1M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while SCYX trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas SCYX's P/E ratio is -1.49. In terms of profitability, SDEV's ROE is +7.90%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, SDEV is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check SCYX's competition here
Cerenome, Inc. (NASDAQ: CNSY)
SDEV vs CNSY Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CNSY has a market cap of 20.6M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CNSY trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CNSY's P/E ratio is -0.42. In terms of profitability, SDEV's ROE is +7.90%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, SDEV is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
SDEV vs BFRI Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, BFRI has a market cap of 18.9M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while BFRI trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas BFRI's P/E ratio is -2.69. In terms of profitability, SDEV's ROE is +7.90%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, SDEV is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check BFRI's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
SDEV vs BFRIW Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, BFRIW has a market cap of 16.7M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while BFRIW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas BFRIW's P/E ratio is -0.03. In terms of profitability, SDEV's ROE is +7.90%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, SDEV is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
SDEV vs COSM Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, COSM has a market cap of 11.6M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while COSM trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas COSM's P/E ratio is -0.29. In terms of profitability, SDEV's ROE is +7.90%, compared to COSM's ROE of -1.19%. Regarding short-term risk, SDEV is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check COSM's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
SDEV vs CJJD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CJJD's P/E ratio is -0.46. In terms of profitability, SDEV's ROE is +7.90%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, SDEV is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
SDEV vs SSY Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas SSY's P/E ratio is -2.86. In terms of profitability, SDEV's ROE is +7.90%, compared to SSY's ROE of -0.09%. Regarding short-term risk, SDEV is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
SDEV vs POM Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, POM has a market cap of 6.5M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while POM trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas POM's P/E ratio is -0.19. In terms of profitability, SDEV's ROE is +7.90%, compared to POM's ROE of +0.16%. Regarding short-term risk, SDEV is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check POM's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
SDEV vs BGMS Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, BGMS has a market cap of 4.9M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while BGMS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas BGMS's P/E ratio is -0.25. In terms of profitability, SDEV's ROE is +7.90%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, SDEV is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check BGMS's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
SDEV vs PAVS Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, PAVS has a market cap of 4.3M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while PAVS trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas PAVS's P/E ratio is -0.06. In terms of profitability, SDEV's ROE is +7.90%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, SDEV is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check PAVS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
SDEV vs MDVL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas MDVL's P/E ratio is -0.05. In terms of profitability, SDEV's ROE is +7.90%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, SDEV is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
SDEV vs ATNFW Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas ATNFW's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, SDEV is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
SDEV vs BGMSP Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, SDEV's ROE is +7.90%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, SDEV is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
SDEV vs AZNH Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas AZNH's P/E ratio is 38.35. In terms of profitability, SDEV's ROE is +7.90%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, SDEV is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check AZNH's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
SDEV vs PRPH Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, PRPH has a market cap of 346.2K. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while PRPH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas PRPH's P/E ratio is -0.01. In terms of profitability, SDEV's ROE is +7.90%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, SDEV is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check PRPH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
SDEV vs LFLYW Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, SDEV's ROE is +7.90%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, SDEV is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check LFLYW's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
SDEV vs ESRX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas ESRX's P/E ratio is 10.69. In terms of profitability, SDEV's ROE is +7.90%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, SDEV is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check ESRX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
SDEV vs CPD Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, CPD has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas CPD's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to CPD's ROE of N/A. Regarding short-term risk, SDEV is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check CPD's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
SDEV vs OREX Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, OREX has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas OREX's P/E ratio is -0.14. In terms of profitability, SDEV's ROE is +7.90%, compared to OREX's ROE of -0.54%. Regarding short-term risk, SDEV is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for SDEV.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
SDEV vs IPXL Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas IPXL's P/E ratio is -10.11. In terms of profitability, SDEV's ROE is +7.90%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, SDEV is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
SDEV vs POZN Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, POZN has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas POZN's P/E ratio is N/A. In terms of profitability, SDEV's ROE is +7.90%, compared to POZN's ROE of +0.61%. Regarding short-term risk, SDEV is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check POZN's competition here
Shire plc (NASDAQ: SHPG)
SDEV vs SHPG Comparison August 2026
Stablecoin Development Corp. (AMEX: SDEV) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDEV stands at 57M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, SDEV is priced at $1.14 on the AMEX, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDEV currently has a P/E ratio of -0.20, whereas SHPG's P/E ratio is 11.35. In terms of profitability, SDEV's ROE is +7.90%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, SDEV is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for SDEV.Check SHPG's competition here